TRANSUNION ($TRU) posted quarterly earnings results for Q1 2026 on Tuesday, April 28th. The company reported earnings of $1.18 per share, beating estimates of $1.11 by $0.07. The company also reported revenue of $1,245,700,000, beating estimates of $1,222,653,762 by $23,046,238.
You can see Quiver Quantitative's $TRU stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TRANSUNION Insider Trading Activity
TRANSUNION insiders have traded $TRU stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $TRU stock by insiders over the last 6 months:
- STEVEN M CHAOUKI (President, US Markets) has made 0 purchases and 5 sales selling 13,000 shares for an estimated $983,420.
- HEATHER J RUSSELL (EVP, Chief Legal Officer) has made 0 purchases and 2 sales selling 6,050 shares for an estimated $473,303.
- TIFFANI CHAMBERS (EVP, Chief Operations Officer) sold 4,318 shares for an estimated $371,348
- TODD C. SKINNER (President, International) has made 0 purchases and 4 sales selling 2,000 shares for an estimated $157,385.
- JENNIFER A. WILLIAMS (SVP, Chief Accounting Officer) sold 1,679 shares for an estimated $134,320
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
TRANSUNION Hedge Fund Activity
We have seen 268 institutional investors add shares of TRANSUNION stock to their portfolio, and 312 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DODGE & COX added 9,842,006 shares (+inf%) to their portfolio in Q4 2025, for an estimated $843,952,014
- INDEPENDENT FRANCHISE PARTNERS LLP added 4,561,619 shares (+99.7%) to their portfolio in Q4 2025, for an estimated $391,158,829
- FARALLON CAPITAL MANAGEMENT LLC removed 4,057,075 shares (-85.7%) from their portfolio in Q4 2025, for an estimated $347,894,181
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,759,939 shares (-76.3%) from their portfolio in Q4 2025, for an estimated $322,414,769
- APG ASSET MANAGEMENT N.V. removed 3,389,850 shares (-96.7%) from their portfolio in Q4 2025, for an estimated $290,679,637
- VICTORY CAPITAL MANAGEMENT INC removed 3,188,762 shares (-97.6%) from their portfolio in Q4 2025, for an estimated $273,436,341
- FMR LLC added 2,792,325 shares (+166.4%) to their portfolio in Q4 2025, for an estimated $239,441,868
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
TRANSUNION Government Contracts
We have seen $210,502 of award payments to $TRU over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TLOXP WEB-BASED DATA REPOSITORY: $106,000
- DEPARTMENT OF INTERIOR, OFFICE OF THE INSPECTOR GENERAL TRANSUNION RISK AND ALTERNATIVE DATA SOLUTIONS, INC...: $12,136
- TLOXP ANNUAL SUBSCRIPTION: $10,080
- THE PURPOSE OF THIS PURCHASE ORDER IS THAT THE CONTRACTOR SHALL PROVIDE TLOXP SUPPORT SERVICES. TLOXP ONLIN...: $9,360
- TITLE: KCDO/GROUP 49A/RECUR/TRANSUNION/ACCOUNT#4447940 REQUESTOR: SANDY C VASQUEZ POP DATES: 09/30/2025 TO ...: $8,400
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
TRANSUNION Analyst Ratings
Wall Street analysts have issued reports on $TRU in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/13/2026
To track analyst ratings and price targets for TRANSUNION, check out Quiver Quantitative's $TRU forecast page.
TRANSUNION Price Targets
Multiple analysts have issued price targets for $TRU recently. We have seen 8 analysts offer price targets for $TRU in the last 6 months, with a median target of $84.0.
Here are some recent targets:
- Sean Kennedy from Mizuho set a target price of $80.0 on 04/16/2026
- Kevin Mcveigh from UBS set a target price of $69.0 on 04/13/2026
- Toni Kaplan from Morgan Stanley set a target price of $100.0 on 03/11/2026
- Toni Kaplan from Goldman Sachs set a target price of $80.0 on 02/17/2026
- Kyle Peterson from Needham set a target price of $95.0 on 02/13/2026
- Jason Haas from Wells Fargo set a target price of $90.0 on 02/13/2026
- Manav Patnaik from Barclays set a target price of $80.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
